Your browser doesn't support javascript.
loading
[Efficacy and safety of pegylated interferon alpha-2b for patients with myeloproliferative neoplasm].
Teng, G S; Zhang, Y H; Wang, Y; Du, C X; Li, Y Q; Hu, N B; Xiang, G P; Shao, Z H; Bai, J.
Affiliation
  • Teng GS; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Zhang YH; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Wang Y; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Du CX; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Li YQ; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Hu NB; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Xiang GP; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Shao ZH; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Bai J; Department of Hematology, the Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Zhonghua Yi Xue Za Zhi ; 103(45): 3645-3651, 2023 Dec 05.
Article in Zh | MEDLINE | ID: mdl-38018063

Full text: 1 Database: MEDLINE Main subject: Vascular Endothelial Growth Factor A / Neoplasms Limits: Female / Humans / Male Language: Zh Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Vascular Endothelial Growth Factor A / Neoplasms Limits: Female / Humans / Male Language: Zh Year: 2023 Type: Article